Two of the most widely known brand names associated with Semaglutide are Wegovy and Ozempic
Leidy HJ, Clifton PM, Astrup A, et al
The great majority of BPC-157 research is preclinical, meaning animal and laboratory models rather than large human trials
Phase 3: the REDEFINE trials The Phase 3 programme for CagriSema is conducted under the name REDEFINE a series of large, randomised, controlled trials designed to confirm efficacy and establish the safety profile required for regulatory approval
For semaglutide specifically, it's advised to stop treatment at least 2 months before a planned pregnancy
Overall, our data suggest that systemic administration of SEM, initiated on the same day as OHT was induced, does not prevent the OHT-associated RGC-loss, but delays the magnitude of IOP increase, delays or partially prevents astrocyte remodeling, and provides mild vasoprotection